sacituzumab govitecan
gilead sciences
['tropics-02']
abstract presentation 2: hope s. rugo, fasco on primary results from tropics-02 we are just 15 minutes in, and this session is incredible! #asco22 
https://t.co/UwVNWBw7PM is a A 501(c)3 nonprofit providing education, community, & resources to those diagnosed with #breastcancer.